🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Spreading of SARS-CoV-2 from hamsters to humans thelancet.com/journals/lance… our comment on doi.org/10.1016/S0140-…

New preprint: Pulmonary lesions following inoculation with Omicron in hamsters. Great work from Melanie Rissmann with help from Bart Haagmans 🦠🐪 🤧 Rory de Vries Debby van Riel @thijskuiken Marion Koopmans, publications: https://pure.eur.nl and many others. biorxiv.org/content/10.110…

In our recent review in Nat Rev Micr (rdcu.be/cKbdj), we explore recent advances regarding SARS-CoV-2 pathophysiology, specifically focusing on new insights obtained using technologies such as single-cell omics, organoid infection models and CRISPR screens. Mart Lamers

Alright, the SAVE (SARS-CoV-2 Assessment of Viral Evolution program) paper is out! "Defining the risk of SARS-CoV-2 variants on immune protection" nature.com/articles/s4158…

SARS-CoV-2 pathogenesis nature.com/articles/s4157… Bart Haagmans 🦠🐪 🤧 and Mart Lamers explore recent clinical and experimental advances in understanding SARS-CoV-2 pathogenesis, interactions with host cells and the involvement of the immune system in the development of severe disease.

Congratulations Bart Collet Haagmans for the @escmidd 2022 excellence award

Our 87G7 manuscript is now online Science Immunology! 🎉 science.org/doi/10.1126/sc… Thank you (and congrats) to the entire MANCO Project team! Wenjuan Du, Daniel Hurdiss, Ieva Drulyte, Bart Haagmans 🦠🐪 🤧, Luis Enjuanes, onehealth, Horizon2020Projects, DFG public | @[email protected], @SURF_onderzoek Utrecht University

A new Report finds that #Omicron BA1 and BA2 subvariants are antigenically distinct, offering insight into the #SARSCoV2 Spike antigen’s evolution and future vaccine development. ➡️ fcld.ly/1cltkzs

Our new paper is out now! Persistence of MERS-CoV spike specific B cells and antibody responses induced by the MERS vaccine candidate MVA-MERS-S. Great work by Marie Weskamm and thanks for the great collaboration @SBeckerLab Bart Haagmans 🦠🐪 🤧 cell.com/cell-reports-m…

First observations on vaccinia and monkeypox specific responses in person with infection and vaccination, with and without historic smallpox vaccination medrxiv.org/content/10.110… great teamwork again Rory de Vries Corine GeurtsvanKessel Bart Haagmans 🦠🐪 🤧 GGD Rotterdam-Rijnmond Mart Lamers

This study is the result of another team effort between well prepared clinicians, virologists, public health specialists and others, honoured to work with all of them! Rory de Vries Luca Zaeck 🦠🔬 Marion Koopmans, publications: https://pure.eur.nl Bart Haagmans 🦠🐪 🤧 Nature Medicine @BayAreaBioEd Erasmus MC

Historic #smallpox vaccination and #monkeypox virus (MPXV) infection elicit MPXV-neutralizing antibodies, but these responses are of lower magnitude after vaccination with MVA-BN, the #vaccine in use for protection against MPXV and smallpox Corine GeurtsvanKessel nature.com/articles/s4159…

Mapping XBB.1's antigenic distance (among others): "We observed that human post-vaccination neutralisation titres reflected the antigenic map, as the largest reduction in neutralising titres compared with the D614G variant" thelancet.com/journals/lanmi… The Lancet Microbe Bart Haagmans 🦠🐪 🤧

Our latest research is now online Frontiers - Immunology! Wenjuan Du et al made a hexavalent biparatopic HCAb targeting the SARS-CoV-2 spike. This molecule neutralised multiple VOCs, whereas the parental HCAbs lost potency. Congrats to everyone involved! frontiersin.org/articles/10.33…

The HERA laboratory network, called DURABLE, kick off is now 🥳 Coming together in Paris with the common goal of advancing health security. DURABLE will provide rapid, high-quality scientific information to support 🇪🇺 preparedness & response to cross-border health threats.

My first paper is out! We identified the intestines of Nathusius's Pipistrelle Bats as a replication site of a naturally occuring Betacoronavirus to contribute to our knowledge on interactions of bat coronaviruses in their natural hosts. journals.asm.org/doi/10.1128/jv…

Our recent study to further characterization a MVA-MERS vaccine candidate: Monkeypox Virus Cross-Neutralizing Antibodies in Clinical Trial Subjects Vaccinated with Modified Vaccinia Virus Ankara Encoding MERS-Coronavirus Spike Protein academic.oup.com/jid/advance-ar…

Very proud of our new paper that demonstrates the importance of respiratory transmembrane mucins in defense against SARS-CoV-2. A true collaborate effort with Bart Haagmans 🦠🐪 🤧 and Utrecht Virology Lab that started in the first lockdown of the corona pandemic. journals.plos.org/plospathogens/…